Morning Briefing
Summaries of health policy coverage from major news organizations
AARP: Cost Of Brand Name Drugs Rose 9.7% Last Year
"The AARP says that manufacturer prices for brand-name prescription drugs commonly used by people on Medicare rose 9.7% for the year ending in March - the biggest annual jump since the group started tracking prices in 2002," The Wall Street Journal Health Blog reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
